The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.9 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Catalyst Trusteeship Ltd, acting as debenture trustee for API Holdings Ltd, has reported a fresh pledge creation on 6,46,46,464 equity shares of Thyrocare Technologies. These are bonus shares issued by Thyrocare (which appear to have doubled the share count from 5.30 crore to 15.91 crore shares) that were auto-pledged by Docon Technologies Pvt Ltd, a promoter group entity, to secure API Holdings' non-convertible debentures. Post this, total encumbered shares stand at 9,69,69,696, representing 60.93% of Thyrocare's total share capital. Voting rights also doubled from 3.23 crore to 9.69 crore shares (60.73% of diluted capital) due to the bonus issue. The acquirer is not part of the promoter group; this is purely a pledge/encumbrance disclosure, not a change in beneficial ownership.
No change in actual ownership or voting control — the pledge was created automatically on bonus shares issued to an already-pledged holding. However, shareholders should note that over 60% of Thyrocare's share capital is now encumbered, which is a high pledge concentration and could pose risks if debenture obligations are triggered. Watch for any future disclosure of pledge invocation or release.